Join FDLI and Peter Pitts, President of the Center for Medicine in the Public Interest, at the next virtual “Author Happy Hour” to discuss the Winter 2020 Update magazine article, “The Question of Mitigating Patient Mortality: Comparing Gilead’s ACTT-1 and the WHO’s Solidarity Trials.” Along with your peers in the food and drug law community, be prepared to engage in a dialogue on the topics presented in the article, including interpreting data to advance the development of diagnostics, therapeutics, and vaccines, all while enjoying your favorite beverage. This member-only benefit will be limited to twenty attendees to encourage active dialogue in a virtual setting.
Author and Article
February 11, 2021
5:00 PM
Registration is open to FDLI members only and is first come, first served. Tickets are limited to 20 participants to facilitate conversation.
This is a complimentary event.
Questions About FDLI Membership?
Contact our membership team at [email protected].
For other questions, please contact Paige Samson.
PETER J. PITTS, a former FDA Associate Commissioner, is President of the Center for Medicine in the Public Interest and a visiting professor at the University of Paris, Descartes School of Medicine. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (the official DIA journal), a member of the External Advisory Board, IMS Institute for Healthcare Informatics in Asia, Executive Advisory Board, the Galien Foundation, Editorial Advisory Board, Food and Drug Policy Forum, Advisory Board, Journal of Commercial Biotechnology and a member of the Editorial Advisory Board of The Patient Magazine. Pitts lives in New York City.
